Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP4F2 | P78329 | 3/20 | 0.42 |
| ▸ | CYP4A11 | Q02928 | 3/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.42 |
| ▸ | PKM | P14618 | 3/20 | 0.40 |
| ▸ | MMP8 | P22894 | 2/20 | 0.40 |
| ▸ | LMNA | P02545 | 1/20 | 0.40 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.39 |
| ▸ | MEN1 | O00255 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.39 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.39 |
| ▸ | MGAM | O43451 | 1/20 | 0.39 |
| ▸ | GAA | P10253 | 1/20 | 0.39 |
| ▸ | SI | P14410 | 1/20 | 0.39 |
| ▸ | MGAM2 | Q2M2H8 | 1/20 | 0.39 |
| ▸ | SOAT1 | P35610 | 1/20 | 0.39 |
| ▸ | THRB | P10828 | 1/20 | 0.38 |
| ▸ | ABCB11 | O95342 | 1/20 | 0.38 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.38 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2169861 | 0.82 | ALOX15 (0.41) | CYP4F2CYP4A11ALDH1A1PKMMMP8 | |
| SCHEMBL15802691 | 0.82 | HCAR2 (0.36) | ALDH1A1LMNAHSD17B10CYP1A2CYP3A4 | |
| SCHEMBL23644313 | 0.82 | CYP4F2 (0.40) | CYP4F2CYP4A11ALDH1A1PKMMMP8 | |
| SCHEMBL27709308 | 0.80 | CYP4F2 (0.39) | CYP4F2CYP4A11ALDH1A1PKMMMP8 | |
| SCHEMBL10277380 | 0.79 | CYP4F2 (0.41) | CYP4F2CYP4A11ALDH1A1PKMMMP8 | |
| SCHEMBL11675418 | 0.79 | CYP4F2 (0.41) | CYP4F2CYP4A11ALDH1A1PKMMMP8 | |
| SCHEMBL27540559 | 0.77 | CYP4F2 (0.40) | CYP4F2CYP4A11ALDH1A1PKMMMP8 | |
| SCHEMBL22841351 | 0.77 | PKM (0.39) | CYP4F2CYP4A11ALDH1A1PKMMMP8 | |
| SCHEMBL19619691 | 0.76 | NAAA (0.50) | ALDH1A1LMNATSHR | |
| SCHEMBL4427462 | 0.75 | MMP8 (0.47) | CYP4F2CYP4A11ALDH1A1PKMMMP8 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230365608-A1 | ANTIVIRAL NUCLEOSIDES AND DERIVATIVES THEREOF | JANSSEN BIOPHARMA, LLC | 2023-11-16 | — | — | US | disclosed |
| US-10179102-B2 | Hair conditioner for wavy and curly hair | KAO USA, INC. (US) | 2019-01-15 | — | — | US | disclosed |
| US-20180185264-A1 | HAIR CONDITIONER FOR WAVY AND CURLY HAIR | KAO USA INC. | 2018-07-05 | — | — | US | disclosed |
| US-9630989-B2 | Dipeptide analogs for treating conditions associated with amyloid fibril formation | RAMOT AT TEL-AVIV UNIVERSITY LTD. (IL) | 2017-04-25 | — | — | US | disclosed |
| US-9630989-B2 | Dipeptide analogs for treating conditions associated with amyloid fibril formation | RAMOT AT TEL-AVIV UNIVERSITY LTD. (IL) | 2017-04-25 | — | — | US | disclosed |
| US-9096645-B2 | Dipeptide analogs for treating conditions associated with amyloid fibril formation | RAMOT AT TEL-AVIV UNIVERSITY LTD. (IL) | 2015-08-04 | — | — | US | disclosed |
| US-9096645-B2 | Dipeptide analogs for treating conditions associated with amyloid fibril formation | RAMOT AT TEL-AVIV UNIVERSITY LTD. (IL) | 2015-08-04 | — | — | US | disclosed |
| US-20150079163-A1 | ANTIMICROBIAL COMPOUNDS AND METHODS OF USE | NEXMED HOLDINGS, INC. | 2015-03-19 | — | — | US | disclosed |
| CN-1993327-B | 3-carbamoyl-2-pyridone derivatives | SHIONOGI & CO | 2013-02-06 | — | — | CN | disclosed |
| US-20120238750-A1 | AROMATIC COMPOUND | OTSUKA PHARMACEUTICAL CO., LTD. | 2012-09-20 | — | — | US | disclosed |
| US-8236826-B2 | Diarylether derivatives as antitumor agents | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 2012-08-07 | — | — | US | disclosed |
| US-8188277-B2 | Aromatic compounds for suppressing the generation of collagen | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 2012-05-29 | — | — | US | disclosed |
| US-20100004438-A1 | DIARYLETHER DERIVATIVES AS ANTITUMOR AGENTS | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 2010-01-07 | — | — | US | disclosed |
| US-20070270422-A1 | Aromatic Compounds | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 2007-11-22 | — | — | US | disclosed |
| US-20070270422-A1 | Aromatic Compounds | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 2007-11-22 | — | — | US | disclosed |
| WO-2007066784-A2 | DIARYLETHER DERIVATIVES AS ANTITUMOR AGENTS | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 2007-06-14 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10179102-B2 | Hair conditioner for wavy and curly hair | ITCH, PARG, GABBR1 | CYP4F2 4455/4885CYP4A11 4519/4885ALDH1A1 3815/4885 |
| US-20180185264-A1 | HAIR CONDITIONER FOR WAVY AND CURLY HAIR | ITCH, PARG, GABBR1 | CYP4F2 4455/4885CYP4A11 4519/4885ALDH1A1 3815/4885 |
| US-20150079163-A1 | ANTIMICROBIAL COMPOUNDS AND METHODS OF USE | CLPP, POLR1C, NACA | CYP4F2 4590/4885CYP4A11 4617/4885ALDH1A1 2055/4885 |
| US-20120238750-A1 | AROMATIC COMPOUND | CBR1, CBR3, CYP1A1 | CYP4F2 546/4885CYP4A11 159/4885ALDH1A1 565/4885 |
| US-20230365608-A1 | ANTIVIRAL NUCLEOSIDES AND DERIVATIVES THEREOF | PNP, NUDT1, ADAR | CYP4F2 3402/4885CYP4A11 2615/4885ALDH1A1 3258/4885 |
| US-20100004438-A1 | DIARYLETHER DERIVATIVES AS ANTITUMOR AGENTS | ROS1, CBR1, CBR3 | CYP4F2 2279/4885CYP4A11 1486/4885ALDH1A1 265/4885 |
| US-20070270422-A1 | Aromatic Compounds | COL1A1, COL2A1, COL14A1 | CYP4F2 435/4885CYP4A11 183/4885ALDH1A1 475/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.